Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $4.5 million.

  • Beta Bionics' Accounts Payables changed N/A to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2024, which is 14459.69% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Accounts Payables is $4.5 million.
  • Beta Bionics' Accounts Payables' 5-year high stood at $4.5 million during Q3 2025, with a 5-year trough of $1.2 million in Q4 2023.
  • Its 3-year average for Accounts Payables is $3.1 million, with a median of $3.4 million in 2025.
  • Over the last 5 years, Beta Bionics' Accounts Payables had its largest YoY gain of 14459.69% in 2024, and its largest YoY loss of 14459.69% in 2024.
  • Beta Bionics' Accounts Payables (Quarter) stood at $1.2 million in 2023, then surged by 144.6% to $2.9 million in 2024, then skyrocketed by 56.42% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q3 2025, $3.4 million for Q2 2025, and $3.5 million during Q1 2025.